Results 71 to 80 of about 157 (83)
Some of the next articles are maybe not open access.
Journal of Pharmacology and Experimental Therapeutics, 1999
LY315920 is a potent, selective inhibitor of recombinant human, group IIA, nonpancreatic secretory PLA2 (sPLA2). In a chromogenic isolated enzyme assay, LY315920 inhibited sPLA2 activity with an IC50 of 9 +/- 1 nM or 7.3 x 10(-6) mole fraction, which approached the stiochiometric limit of this assay.
Niles Fox +2 more
exaly +3 more sources
LY315920 is a potent, selective inhibitor of recombinant human, group IIA, nonpancreatic secretory PLA2 (sPLA2). In a chromogenic isolated enzyme assay, LY315920 inhibited sPLA2 activity with an IC50 of 9 +/- 1 nM or 7.3 x 10(-6) mole fraction, which approached the stiochiometric limit of this assay.
Niles Fox +2 more
exaly +3 more sources
Neutralizing properties of LY315920 toward snake venom group I and II myotoxic phospholipases A2
Toxicon, 2019José Maria Gutierrez +2 more
exaly
Structural and Functional Aspects of Targeting the Secreted Human Group IIA Phospholipase A2
Molecules, 2020Kieran Scott +2 more
exaly
Indole Inhibitors of Human Nonpancreatic Secretory Phospholipase A2. 3. Indole-3-glyoxamides
Journal of Medicinal Chemistry, 1996David W Snyder, Noel D Jones, D W Snyder
exaly
Highly Specific and Broadly Potent Inhibitors of Mammalian Secreted Phospholipases A2
Journal of Medicinal Chemistry, 2008Michael Gelb +2 more
exaly

